Penn Capital Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
Penn Capital Management's HALO Position: Q4 2024 in Review
Penn Capital Management sold out of Halozyme (HALO) in Q4 2024, closing a stake of 266,167 shares — an estimated $15.3M sold.
Penn Capital Management first reported a position in HALO in Q1 2020 and held it in 19 quarters. The position peaked at $16.4M in Q4 2022. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.
- Penn Capital Management reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
- Penn Capital Management sold 266,167 Halozyme shares in Q4 2024, an estimated $15.3M.
- Penn Capital Management first reported a position in Halozyme in Q1 2020 and held it in 19 quarters.
- Penn Capital Management's Halozyme position peaked at $16.4M in Q4 2022.
- 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.
Based on Penn Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.